Tobacco Control

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pilkington, P
Right arrow Articles by Gilmore, A B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pilkington, P
Right arrow Articles by Gilmore, A B
Related Collections
Right arrow Environmental tobacco smoke
Tobacco Control 2004;13:375-378
© 2004 BMJ Publishing Group Ltd


RESEARCH PAPER

The Living Tomorrow Project: how Philip Morris has used a Belgian tourist attraction to promote ventilation approaches to the control of second hand smoke

P Pilkington, A B Gilmore

European Centre on Health of Societies in Transition, London School of Hygiene and Tropical Medicine, London, UK

Correspondence to:
Paul Pilkington
University of the West of England, Faculty of Health and Social Care, Glenside Campus, Blackberry Hill, Stapleton, Bristol, BS16 1DD, UK; paul.pilkington{at}uwe.ac.uk

Study objective: To examine the involvement of Philip Morris in Living Tomorrow 2 and determine the rationale behind its involvement.

Design: Research was conducted through a web based search of internal tobacco industry documents made publicly available through litigation.

Main results: For approximately {euro}1 000 000 Philip Morris (now Altria) became a co-initiator of Living Tomorrow 2, a tourist complex in Belgium that aims to demonstrate how we will be living in the future. In addition to promoting the company and its grocery products, Philip Morris is using the complex and its website to promote ventilation as a means of accommodating smokers and non-smokers in the indoor environment. Particular emphasis was placed on the bar and restaurant areas. Despite the rationale for its involvement, Philip Morris fails to acknowledge its role as a cigarette manufacturer. As a form of corporate sponsorship Philip Morris thought its involvement could evade any European tobacco advertising ban.

Conclusions: Philip Morris is using a tourist attraction to promote its views on control of second hand smoke (SHS) and accommodation of smokers and non-smokers in the indoor environment. However, ventilation does not deal with the health effects of SHS. Policymakers must be cognisant of the devious tactics the industry employs to promote its own agenda, especially in relation to indoor air quality and smoking in public places. Tobacco control legislation should be continually modified and strengthened in response to the changing activities of the tobacco industry as it strives to evade existing legislation and deter the advent of new legislation.


Abbreviations: EU, European Union; HBI, Healthy Buildings International; HVAC, heating, ventilation, and air conditioning; SHS, second hand smoke

Keywords: Sponsorship; tobacco industry; ventilation




This article has been cited by other articles:


Home page
Tobacco ControlHome page
P A McDaniel, E A Smith, and R E Malone
Philip Morris's Project Sunrise: weakening tobacco control by working with it
Tob. Control, June 1, 2006; 15(3): 215 - 223.
[Abstract] [Full Text] [PDF]


Home page
Tobacco ControlHome page
P M Ling and S A Glantz
Tobacco industry consumer research on socially acceptable cigarettes
Tob. Control, October 1, 2005; 14(5): e3 - e3.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 by the BMJ Publishing Group Ltd.